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Although potentially hazardous environmental exposures are
ubiquitous, the development of diseases from direct environmen-
tal causes is, fortunately, limited. For most diseases, environmen-
tal exposures represent one of several factors contributing to the
development and progression of disease. Other factors include
variation in genetic susceptibility, the presence of other condi-
tions or diseases, diet, activity level, and medications taken. In
addition, whether an individual develops disease as a function of
environmental exposure also depends on the agent, the extent of
exposure, and the timing of exposure. Nevertheless, the complex
interaction between these factors accounts for the development of
the majority of common diseases in the United States, including
asthma, diabetes mellitus, atherosclerosis, and many types of can-
cer. The question we’d like for you to consider is what tools are
needed to understand the role of environmental exposures in the
development of common complex diseases. 
Traditional methods for human exposure assessment involve
measuring exposure concentrations in the ambient environment
and extrapolating to potential points of human contact, as well as
measuring the concentration of parent compounds or their
metabolites in biological samples (biomonitoring). However, both
these methods are problematic: measures of the ambient environ-
ment represent only rough estimates of an individual’s exposures,
and biomonitoring provides only transient estimates of exposure. 
We believe the time is right to advance a new science focused
on the interface between exposures and human health.
Technologies currently exist for the global analysis of genes
(genomics), gene transcripts (transcriptomics), proteins (pro-
teomics), and metabolites (metabolomics). Emerging fields, such
as medical imaging, nanotechnology, and sensor technology are
beginning to yield products that affect the way we conduct
research and are proving useful in homeland security and biode-
fense. Our view is that these technologies also represent impor-
tant opportunities for providing tools that could advance our
understanding of disease etiology by providing quantitative
methods to assess the temporal and biological response to multi-
ple environmental exposures. Ideally, these new technologies will
generate insight on exposures across the exposure–disease con-
tinuum, from the point of human contact to the internal dose to
the early biological response (see figure above).
Our vision at the NIEHS is to use environmental health sciences
to understand human disease and improve human health.
Fundamental to this vision is the ability
to quantify an individual’s exposure, as
well as the unique characteristics that
account for individualized responses to
common exposures. To achieve this
ability, we must develop an exposure
biology initiative that will provide the
same degree of individual-level preci-
sion that is being achieved through the
sequencing of the human genome.
While this will not be easy, the impact of this scientific infrastruc-
ture on advancing our understanding of disease etiology and patho-
genesis will be profound; in the absence of this infrastructure, it will
remain difficult to evaluate the relationship between environmental
exposures and human health. To the extent feasible, new technologi-
cal developments should complement efforts that are ongoing in the
public and private sectors, such as biodefense and national health sur-
veillance. Realistically, investments will
be needed in long-term research and
training programs to enhance the pre-
cision and applicability of environ-
mental exposure measurements to
human health research.
As part of its strategic planning
process, the NIEHS will establish
priorities and develop a plan to move
exposure health sciences forward. The
emphasis will be on advancing our
knowledge of gene-environment inter-
actions in model disease processes.
Deciphering the environmental and
genetic risk factors for disease develop-
ment and progression, specifically the interaction between environ-
mental exposures and gene differences, will enable researchers and
clinicians to develop better strategies for modifying risk and treating
disease. Hence, the ability to develop, validate, and correlate expo-
sure-response indicators with allele variation will be critical to our
success in reducing the burden of human disease. As always, we look
forward to your comments.
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The question to consider 
is what tools are needed to
understand the role of 
environmental exposures 
in the development of 
common complex diseases. 
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